<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 7 Bioavailability of Divalproex Sodium Extended-Release Tablets Relative to Divalproex Sodium Delayed-Release Tablets When Divalproex Sodium Extended-Release Tablets Dose is 8% to 20% Higher</caption>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<tbody>
<tr>
<td align="center">  <content stylecode="bold">Study<br/>Population</content>
</td>
<td align="center" valign="top">  <content stylecode="bold">Regimens</content>
</td>
<td align="center" colspan="3" valign="top">  <content stylecode="bold">Relative Bioavailability</content>
</td>
</tr>
<tr>
<td align="center" stylecode="     Botrule     ">   </td>
<td align="center" stylecode="     Botrule     ">  Divalproex Sodium<br/>Extended-Release<br/>Tablets vs.<br/>Divalproex Sodium<br/>Delayed-Release<br/>Tablets</td>
<td align="center" stylecode="     Botrule     ">  AUC<sub>24</sub>
</td>
<td align="center" stylecode="     Botrule     ">  C<sub>max</sub>
</td>
<td align="center" stylecode="     Botrule     ">  C<sub>min</sub>
</td>
</tr>
<tr>
<td align="center">  Healthy Volunteers<br/>(N = 35)</td>
<td align="center">  1000 mg &amp; 1500 mg<br/>Divalproex Sodium<br/>Extended-Release<br/>Tablets vs.<br/>875 mg &amp; 1250 mg<br/>Divalproex Sodium<br/>Delayed-Release<br/>Tablets</td>
<td align="center">  1.059</td>
<td align="center">  0.882</td>
<td align="center">  1.173</td>
</tr>
<tr>
<td align="center">  Patients with epilepsy on<br/>concomitant enzyme-<br/>inducing antiepilepsy<br/>drugs (N = 64)</td>
<td align="center">  1000 mg to 5000 mg<br/>Divalproex Sodium<br/>Extended-Release<br/>Tablets vs.<br/>875 mg to 4250 mg<br/>Divalproex Sodium<br/>Delayed-Release<br/>Tablets</td>
<td align="center">  1.008</td>
<td align="center">  0.899</td>
<td align="center">  1.022</td>
</tr>
</tbody>
</table>